mantle cell lymphoma
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
mantle cell lymphoma
Jul 21, 2024, 12:19 |
Blog
Oncoinfluencers to Follow on Social Media: Dr. Michael Wang
At OncoDaily, we are excited to highlight Dr. Michael Wang, a prominent researcher and clinician…
Jul 13, 2024, 21:06 |
Insight
Michael Wang: CDK9 is a promising target in MCL
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation…
Jul 1, 2024, 02:17 |
Opinion
Michael Wang: Excellent review of the actions and complex regulation of p53
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation…
Jun 29, 2024, 16:57 |
Insight
MD Anderson Research Highlights: EHA 2024 Special Edition
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
Jun 20, 2024, 10:10 |
Insight
Date of improved response rates in mantle cell lymphoma patients
MD Anderson Cancer Center shared on LinkedIn: "Adding the BTK inhibitor acalabrutinib to chemoimmunotherapy shows…
Jun 17, 2024, 17:03 |
Blog
Michael Wang: I presented the data from ECHO trial
Michael Wang, Professor in the Department of Lymphoma/Myeloma and in the Department of Stem Cell…
Apr 15, 2024, 16:12 |
Insight
Michael Wang: Our Phase I TRANSCEND trial demonstrated that Liso-cel results in consistently high objective response rates
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and…
Mar 31, 2024, 23:07 |
Blog
Michael Wang: To my philanthropic donors, I am grateful for your support to further our attack on mantle cell lymphoma
Michael Wang, Professor in the Department of Lymphoma and Myeloma at MD Anderson Cancer Center,…
Jan 3, 2024, 18:41 |
Insight
Julie Vose: The long awaited publication from the NAMCL Project
Julie Vose shared a post on X/Twitter: ''Finally! The long awaited publication from the NAMCL Project!…
Dec 27, 2023, 13:13 |
Insight
Charles Gaulin: Safety of ibrutinib in previously untreated high-risk smoldering mantle cell lymphoma
Charles Gaulin, Lymphoma/Myeloma Fellow at MD Anderson Cancer Center, shared on LinkedIn: "At ASH23, we presented…
All:
10
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube